Imran Talat

Chief Executive Officer, DirectorRani Therapeutics Holdings, Inc. (RANI) · full profile →Form 4 · filed Jul 21, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$11K
Net Open-Market Flow
-$11K
Transactions
7
7 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 27, 2026Tax withholding(F)8K$0.74$6K435K
Mar 27, 2026Tax withholding(F)9K$0.81$7K443K
Mar 22, 2026Tax withholding(F)9K$1.13$10K452K
Dec 27, 2025Tax withholding(F)8K$1.40$11K461K
Sep 27, 2025Tax withholding(F)9K$0.48$4K469K
Jun 27, 2025Tax withholding(F)9K$0.55$5K478K
Dec 27, 2024Sell(S)8K$1.41$11K487K

Transaction Codes

F
Shares withheld for taxes
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001869579-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about RANI insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001869579-26-000006"
Ask your agent
Use Arkolith to summarize insider buying and selling at Rani Therapeutics Holdings, Inc.
over the last 90 days and cite the filings.